37
Participants
Start Date
March 27, 2023
Primary Completion Date
September 5, 2024
Study Completion Date
September 5, 2024
Adynovate
Adynovate was injected intravenously using an appropriately sized syringe as a bolus infusion over a period of less than or equal to (\<=) 5 minutes (maximum infusion rate, 10 milliliters per minute \[mL/min\]).
Beijing Children's Hospital, Capital Medical University, Beijing
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing
Xiangya Hospital of Central South University, Changsha
Fujian Medical University Union Hospital, Fuzhou
Nanfang Hospital Southern Medical University, Guangzhou
Anhui Province Hospital, Hefei
Jinan Central Hospital, Jinan
Shenzhen Second People's Hospital, Shenzhen
The First Affiliated Hospital of Soochow University, Suzhou
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Lead Sponsor
Takeda
INDUSTRY